Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Preliminary phase I data presented on TAK-285 in advanced cancer

Dec. 17, 2010

EpiCept's crolibulin enters phase I/II trial in anaplastic thyroid cancer

Dec. 17, 2010

Tesaro gains development rights to antiemetic rolapitant hydrochloride

Dec. 16, 2010

Orion identifies novel inhibitors of MT-SP1

Dec. 16, 2010

MGN-1601 enters phase I/II study in advanced renal cancer

Dec. 16, 2010

MLN-0905 has antitumor effects in murine model of diffuse large B-cell lymphoma

Dec. 16, 2010

Phase I data support safety of BIIB-021 plus trastuzumab in HER2-positive breast cancer

Dec. 16, 2010

ONO-013105 synergizes with rituximab in models of MCL and advances in phase I trial

Dec. 16, 2010

HG-829 reverses resistance to antineoplastic agents in vitro and in vivo

Dec. 16, 2010

Phase II trial of EGEN-001 in advanced ovarian cancer opens enrollment

Dec. 15, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...